TrialTransplantation and cellular therapy2023

Phase II Study of Myeloablative 7-8/8-Matched Allotransplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil.

Najla El Jurdi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.